The Council of the Convention (CoC) is one of the independent governing bodies that helps lead USP, along with the full Convention Membership, the Board of Trustees, and the Council of Experts. Throughout each five-year cycle, the CoC, comprised of representatives from Convention Member Organizations, represents the full Convention by sharing diverse perspectives with USP, guiding the engagement of the Convention Membership, and making important governance decisions that help USP maximize its impact.
The Essential Role of the Council of the Convention
The CoC meets quarterly to fulfill its governance responsibilities, hear updates on Sector and Chapter activities, provide input on staff updates, and share insights on priority topics. The CoC’s primary duties include:
- Engagement: Guiding and informing engagement of Convention Membership, ensuring Members are appropriately updated and that their perspectives are heard
- Membership: Approving new Associate Members to the Convention and recommending new Voting Member Organizations to the Board of Trustees for final approval
- Resolutions: Overseeing the Resolutions process, issuing the call for Resolutions, and submitting proposed Resolutions to the Convention Membership for consideration and vote
- Bylaws: Developing and reviewing proposed amendments to USP Bylaws and submitting to Convention Membership for consideration and vote
- Voting: Ensuring the integrity of voting processes and tools provided for Convention Membership
- Rules and Procedures: Reviewing the Rules and Procedures of the CoC and the Council of Experts to ensure they’re consistent with USP Bylaws
Council of the Convention 2025 – 2030 Convention
President and CoC Chair: Hanan Sboul
Sector Chairs:
- Generics, Association for Accessible Medicines, Giuseppe Randazzo
- Healthcare Practice, Academy of Managed Care Pharmacy, Susan Cantrell
- Biologics, National Health Council, Randy Rutta
- Dietary Supplements, Obesity Action Coalition, Joe Nadglowski
Regional Chapter Chairs:
- LATAM, Argentine Association of Industrial Pharmacy and Biochemistry, Federico Montes de Oca
- Europe, International Pharmaceutical Federation, Catherine Duggan
- APAC, Therapeutic Goods Administration, Paul Huleatt
- South Asia, Indian Pharmaceutical Alliance, Rajiv Desai
- Africa, South African Health Products Regulatory Authority, Boitumelo Semete
Council of Experts:
- Kenneth Miller, Biologics – Therapeutic Proteins
- Ed Tidswell, Microbiology
- Allan Bokser, Small Molecules Therapeutic Area 6
- Lili Belcastro, Biologics – Cell and Gene Therapies
At-Large:
- Healthcare Supply Chain Association, Angie Boliver
- American Association of Colleges of Pharmacy, Lynette Bradley-Baker
- University of Minnesota College of Pharmacy, Steve Schondelmeyer
- FDA CDER, Pallavi Nithyanandan
- National Council for Prescription Drug Programs, Steve Mullenix
- American Pharmacists Association, Michael Hogue
- National Association of Boards of Pharmacy, Al Carter
- Friends of Cancer Research, Jeff Allen
- Healthcare Distribution Alliance, Nicolette Louissaint
- Howard College of Pharmacy, Ranti Akiyode
- American Society of Health-System Pharmacists, Kasey Thompson